Proceedings from “Amyloidosis, A Hidden Disease with a Bright Future:” A Multi-Disciplinary Approach to Diagnosis and Management of Amyloidosis - American Journal of Medicine
The educational material for this journal-based CME course can be found at The American Journal of Medicine: https://www.amjmed.com/issue/S0002-9343(22)X0005-3.
For CME Credit, Post-Test, and Evaluation:
- Click on a topic/title below and then ENROLL with your CME account.
- Complete the Post-Test and Evaluation to receive your CME Certificate & Credit.
Table of Contents
- Introduction – Kathleen Zhang, Daniel Lenihan
- When Should I Consider the Diagnosis of Amyloidosis – Steven Law, MD and Jullian Gillmore, MD
- How to Manage Cardiac Symptoms with Amyloidosis – Philip King, MD and Andrew Kates, MD, FACC
- Neurologic Involvement in AL and TTR Amyloidosis – Dina Namiranian, MD and Stefanie Geisler, MD
- Management Strategies for GI Involvement with Amyloidosis – Cassandra Fritz, MD and Elizabeth J. Blaney, MD
- What do the Elevated Protein Levels Mean in my Patient with Myeloma and/or AL Amyloidosis? – Scott Goldsmith, MD and Keith Stockerl-Goldstein, MD
- Update on Current Therapy in Conjunction with Stem Cell Transplant for AL Amyloidosis – Maya Abdallah, MD and Vaishali Sanchorawala, MD
- Kidney Involvement in Amyloidosis: Presentations, Diagnosis, and Management – Reena Gurung, MD and Tingting Li, MD, MSCI
- Developing Therapy for ATTR Amyloidosis – Courtney Campbell, MD, Kathleen Zhang, MD, Daniel Lenihan, MD and Ronald Witteles, MD
- COVID-19 and AL Amyloidosis: Adding Insult to Injury – Zachary Crees, MD and Keith Stockerl-Goldstein, MD
- Future Developments in AL Amyloidosis Management – Mario Rodriguez, MD, Daniel Lenihan, MD and Giampaolo Merlini, MD
These presentations are supported by unrestricted educational grants from Alnylam Pharmaceuticals and Janssen Pharmaceuticals.
